These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 21200061)

  • 1. Managing the atazanavir-tacrolimus drug interaction in a renal transplant recipient.
    Tsapepas DS; Webber AB; Aull MJ; Figueiro JM; Saal SD
    Am J Health Syst Pharm; 2011 Jan; 68(2):138-42. PubMed ID: 21200061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of coadministered HIV-protease inhibitors on tacrolimus and sirolimus blood concentrations in a kidney transplant recipient.
    Barau C; Blouin P; Creput C; Taburet AM; Durrbach A; Furlan V
    Fundam Clin Pharmacol; 2009 Aug; 23(4):423-5. PubMed ID: 19709321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of tacrolimus in adult renal transplant recipients.
    Naik P; Madhavarapu M; Mayur P; Nayak KS; Sritharan V
    Drug Metabol Drug Interact; 2012; 27(3):151-5. PubMed ID: 23089531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regimen simplification to atazanavir-ritonavir alone as maintenance antiretroviral therapy after sustained virologic suppression.
    Swindells S; DiRienzo AG; Wilkin T; Fletcher CV; Margolis DM; Thal GD; Godfrey C; Bastow B; Ray MG; Wang H; Coombs RW; McKinnon J; Mellors JW;
    JAMA; 2006 Aug; 296(7):806-14. PubMed ID: 16905786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The interaction between antiretroviral agents and tacrolimus in liver and kidney transplant patients.
    Jain AK; Venkataramanan R; Shapiro R; Scantlebury VP; Potdar S; Bonham CA; Ragni M; Fung JJ
    Liver Transpl; 2002 Sep; 8(9):841-5. PubMed ID: 12200788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical pharmacokinetics and summary of efficacy and tolerability of atazanavir.
    Le Tiec C; Barrail A; Goujard C; Taburet AM
    Clin Pharmacokinet; 2005; 44(10):1035-50. PubMed ID: 16176117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Time-related clinical determinants of long-term tacrolimus pharmacokinetics in combination therapy with mycophenolic acid and corticosteroids: a prospective study in one hundred de novo renal transplant recipients.
    Kuypers DR; Claes K; Evenepoel P; Maes B; Coosemans W; Pirenne J; Vanrenterghem Y
    Clin Pharmacokinet; 2004; 43(11):741-62. PubMed ID: 15301578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tacrolimus and cerivastatin pharmacokinetics and adverse effects after single and multiple dosing with cerivastatin in renal transplant recipients.
    Renders L; Haas CS; Liebelt J; Oberbarnscheidt M; Schöcklmann HO; Kunzendorf U
    Br J Clin Pharmacol; 2003 Aug; 56(2):214-9. PubMed ID: 12895195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal allograft dysfunction associated with rifampin-tacrolimus interaction.
    Chenhsu RY; Loong CC; Chou MH; Lin MF; Yang WC
    Ann Pharmacother; 2000 Jan; 34(1):27-31. PubMed ID: 10669182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinically significant drug-drug interaction between tacrolimus and fluconazole in stable renal transplant recipient and literature review.
    He J; Yu Y; Yin C; Liu H; Zou H; Ma J; Yang W; Liu Y; Zhong L; Chen X
    J Clin Pharm Ther; 2020 Apr; 45(2):264-269. PubMed ID: 31756280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Pharmacokinetics of Once-Daily Tacrolimus in Solid-Organ Transplant Patients.
    Staatz CE; Tett SE
    Clin Pharmacokinet; 2015 Oct; 54(10):993-1025. PubMed ID: 26038096
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary immunosuppression with tacrolimus and low-dose mycophenolate mofetil in renal transplant recipients.
    Yeung S; Tsang WK; Tong KL; Wong SH; Lee W; Tang HL; Chan HW; Chan AY
    Transplant Proc; 2004 Sep; 36(7):2084-6. PubMed ID: 15518754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of tacrolimus and mycophenolate mofetil in renal transplant recipients on a corticosteroid-free regimen.
    Greanya ED; Poulin E; Partovi N; Shapiro RJ; Al-Khatib M; Ensom MH
    Am J Health Syst Pharm; 2012 Jan; 69(2):134-42. PubMed ID: 22215359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical pharmacokinetics of tacrolimus after the first oral administration in combination with mycophenolate mofetil and prednisone in Chinese renal transplant recipients.
    Chen YH; Zheng KL; Chen LZ; Dai YP; Fei JG; Qiu J; Li J
    Transplant Proc; 2005 Dec; 37(10):4246-50. PubMed ID: 16387090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tacrolimus trough levels and level-to-dose ratio in stable renal transplant patients converted to a once-daily regimen.
    Meçule A; Tinti F; Poli L; Bachetoni A; Umbro I; Nofroni I; Lai Q; Pretagostini R; Berloco PB; Mitterhofer AP
    Transplant Proc; 2011 May; 43(4):1024-7. PubMed ID: 21620042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kidney Transplant in a Human Immunodeficiency Virus-Positive Patient: Case Report of Drug Interactions.
    Yılmaz M; Gökengin D; Bozbıyık O; Hoşcoşkun C; Uyan A; Töz H
    Exp Clin Transplant; 2023 Apr; 21(4):365-367. PubMed ID: 28969531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics and inhibitory quotient of atazanavir/ritonavir versus lopinavir/ritonavir in HIV-infected, treatment-naive patients who participated in the CASTLE Study.
    Zhu L; Liao S; Child M; Zhang J; Persson A; Sevinsky H; Eley T; Xu X; Krystal M; Farajallah A; McGrath D; Molina JM; Bertz R
    J Antimicrob Chemother; 2012 Feb; 67(2):465-8. PubMed ID: 22121190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Case report: boldo (Peumus boldus) and tacrolimus interaction in a renal transplant patient.
    Carbajal R; Yisfalem A; Pradhan N; Baumstein D; Chaudhari A
    Transplant Proc; 2014 Sep; 46(7):2400-2. PubMed ID: 24981811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ranolazine-tacrolimus interaction.
    Pierce DA; Reeves-Daniel AM
    Ann Pharmacother; 2010 Nov; 44(11):1844-9. PubMed ID: 20876828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lansoprazole-tacrolimus interaction in Japanese transplant recipient with CYP2C19 polymorphism.
    Takahashi K; Motohashi H; Yonezawa A; Okuda M; Ito N; Yamamoto S; Ogawa O; Inui K
    Ann Pharmacother; 2004 May; 38(5):791-4. PubMed ID: 15010519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.